Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Reexamination Certificate
2011-01-11
2011-01-11
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
C424S001110, C424S009100, C534S007000
Reexamination Certificate
active
07867477
ABSTRACT:
In certain embodiments, methods of the present invention obtain dynamic data sets of an NMR spectroscopy signal of polarized129Xe in a selected structure, environment, or system. The signal data can be used to evaluate: (a) the physiology of a membrane or tissue; (b) the operational condition or function of a body system or portion thereof (when at rest or under stimulation); and/or (c) the efficacy of a therapeutic treatment used to treat a diagnosed disorder, disease, or condition. Thus, the present invention provides methods for screening and/or diagnosing a respiratory, cardiopulmonary disorder or disease such as chronic heart failure, and/or methods for monitoring the efficacy of therapeutics administered to subject to treat the disorder or disease.
REFERENCES:
patent: 4793357 (1988-12-01), Lindstrom
patent: 5190744 (1993-03-01), Rocklage et al.
patent: 5509412 (1996-04-01), Bahn
patent: 5545396 (1996-08-01), Albert et al.
patent: 5572126 (1996-11-01), Shinnar
patent: 5617859 (1997-04-01), Souza et al.
patent: 5617860 (1997-04-01), Chupp et al.
patent: 5642625 (1997-07-01), Cates, Jr. et al.
patent: 5809801 (1998-09-01), Cates, Jr. et al.
patent: 5811076 (1998-09-01), Brasch et al.
patent: 5936404 (1999-08-01), Ladebeck et al.
patent: 6033645 (2000-03-01), Unger et al.
patent: 6051208 (2000-04-01), Johnson et al.
patent: 6079213 (2000-06-01), Driehuys et al.
patent: 6158434 (2000-12-01), Lugtigheid et al.
patent: 6237363 (2001-05-01), Zollinger et al.
patent: 6338836 (2002-01-01), Kuth et al.
patent: 6346229 (2002-02-01), Driehuys et al.
patent: 6370415 (2002-04-01), Weiler et al.
patent: 6491895 (2002-12-01), Driehuys et al.
patent: 6630126 (2003-10-01), Driehuys et al.
patent: 6696040 (2004-02-01), Driehuys
patent: 6808699 (2004-10-01), Driehuys et al.
patent: 6991777 (2006-01-01), Driehuys et al.
patent: 7179450 (2007-02-01), Driehuys et al.
patent: 7357917 (2008-04-01), Driehuys
patent: 2001/0041834 (2001-11-01), Mugler et al.
patent: 2002/0006382 (2002-01-01), Driehuys et al.
patent: 2002/0043267 (2002-04-01), Weiler et al.
patent: 0933062 (1999-04-01), None
patent: 2091884 (1982-04-01), None
patent: WO97/37239 (1997-10-01), None
patent: WO99/07415 (1999-02-01), None
patent: WO99/25243 (1999-05-01), None
patent: WO99/47940 (1999-09-01), None
patent: WO99/52428 (1999-10-01), None
patent: WO99/53332 (1999-10-01), None
patent: WO00/23797 (2000-04-01), None
patent: WO00/40972 (2000-07-01), None
patent: WO01/74246 (2001-10-01), None
patent: WO02/04709 (2002-01-01), None
Albert et al., “Susceptibility Changes Following Bolus Injections”, Appendix B reprint from Magnetic Resonance in Medicine 29 700-708 (1993).
Albert et al., “Measurement of129Xe T1 in Blood to Explore the Feasibility of Hyperpolarized129Xe MRI,” Jour. Comp. Ass. Tomography, vol. 19, No. 6 (Nov.-Dec. 1995).
Albert et al., “129Xe Relaxation Catalysis by Oxygen”, Abstracts of the 11th Annual Meetings of the Society for Magnetic Resonance Medicine, Abstract No. 4710 (1992).
Bachert et al.,Nuclear Magnetic Resonance Imaging of Airways in Humans with Use of Hyperpolarized3He, MRM 36, pp. 192-196 (1996).
Bárány, M. et al., “High Resolution Proton Magnetic Resonance Spectroscopy of Human Brain and Liver,” Magn. Reson. Imaging, 5:393 (1987).
Belliveau et al., Functional Cerebral Imagining by Susceptibility-Contrast NMR, Dated Dec. 7, 1989; Magnetic Resonance in Medicine 14, 538-546 (1990).
Bifone, et al., “NMR of laser-polarized xenon in human blood,” Proc. Natl. Acad. Sci. USA, vol. 93, pp. 12932-12936 (Nov. 1996).
Brookeman, J.R., “MRS and MRI of Hyperpolarized129Xe: Studies in Human Volunteers,” Proc ISMRM (1998).
Brunner et al., “Communications: Gas Flow MRI Using Circulating Laser-Polarized129Xe,” J. Mag. Res. vol. 138, pp. 155-159 (1999).
Chen et al., “MR Microscopy of Lung Airways with Hyperpolarized3He,” Mag. Reson. In Med., vol. 39, No. 1, pp. 79-84 (Jan. 1998).
Chupp et al., “Chemical Shift Imagining of Laser-Polarized129XE Magnetization In Rats in Vivo”, European Radiology 9:B45 (1999).
de Lange et al., “Lung Airspaces: MR Imaging Evaluation with Hyperpolarized Helium-3 Gas,”Radiology 210, 851-857(1999).
Deningcr et al., “Quantification of Regional Intrapulmonary Oxygen Partial Pressure Evolution during Apnea by3He MRI,” J. Mag. Res., vol. 141, pp. 207-216 (1999).
Diehl et al., “Nuclear Magnetic Relaxation of the129Xe and131Xe Isotopes of Xenon Gas Dissolved in Isotropic and Anisotropic Liquids,” J. Magn. Reson., vol. 88, pp. 660-665 (1990).
Donnelly et al., “Cystic Fibrosis: Combined Hyperpolarized 3He-enhanced and Conventional Proton MR Imaging in the Lung—Preliminary Observations,” Radiology 212 (Sep. 1999), 885-889 (1999).
Driehuys et al., “Surface Relaxation Mechanisms of Laser-Polarized129Xe”, Physical Review Letters vol. 74, No. 24, p. 4943-4946, dated Jun. 12, 1995.
Eberle et al., “Analysis of intrapulmonary O2concentration by MR imaging of inhaled hyperpolarized helium-3,” Am. Physiological Soc., pp. 2043-2052 (1999).
Eberle et al., “Determination of Regional Intrapulmonary Oxygen Concentration by Magnetic Resonance Imaging of inhaled Hyperpolarized3Helium,” Anesthesiology, vol. 89, No. 3A (Sep. 1998).
Gao et al., “Magnetization and Diffusion Effects in NMR Imaging of Hyperpolarized Substances”, MRM 37:153-158 (1997).
Goodson et al., “In vivo NMR and MRI Using Injection Delivery of Laser-Polarized Xenon,” 94 Proc. Natl. Acad. Sci. USA, pp. 14725-14729 (1997).
Gregory et al., “Pore Structure Determinations of Silica Aerogels by129Xe NMR Spectroscopy and Imaging,” J. Mag. Reson., vol. 131, No. 2, pp. 327-335 (Apr. 1998).
Grover, B.D., “Noble-Gas NMR Detection through Noble-Gas-Rubidium Hyperfine Contact Interaction,” Phys. Rev. Lett., vol. 40, No. 6, pp. 391-392 (1978).
Hedlund, L. W., M.D. Shattuck, and G.A.Johnson. “Three-dimensional MR microscopy of pulmonary dynamics” in 1996. New York, NY: Society of Magnetic Resonance.
Hou, et al., “Optimization of Fast Acquisition Methods for Whole-Brain Relative Cerebral Blood Volume (rCBV) Mapping with Susceptibility Contrast Agents,” J. Mag. Res. Imaging, vol. 9 pp. 233-239 (1999).
Il'yasov et al., “129Xe NMR in Study of Tissues and Plants,” Appl. Magn. Reson. vol. 17, pp. 17-84, (1999).
Intenrational Search Report and Written Opinionfor PCT/US2004/002782 dated Jun. 25, 2004 dated Jul. 16, 2004.
Jameson et al., “Nuclear Spin Relaxation by Intermolecular Magnetic Dipole Coupling in the Gas Phase. 129Xe in Oxygen,” J. Chem. Phys., vol. 89, p. 4074-4081 (1988).
Kaatz et al., “A comparison of molecular hyperpolarizabilities from gas and liquid,” J. Chem. Phys., vol. 108, No. 3, pp. 849-856 (Jan. 15, 1998).
Kaiser, et al., “Diffusion and field-gradient effects in NMR Fourier spectroscopy,” J. Chem. Phys., vol. 60, No. 8, pp. 2967-2979 (Apr. 15, 1974).
Kauczor et al., “Normal and Abnormal Pulmonary Ventilation: Visualization at Hyperpolarized He-3 MR Imaging1,” Radiology, vol. 201, No. 2, pp. 564-568 (1996).
Le Bihan, “Magnetic Resonance Imaging of Perfusion*,” Mag. Reson. In Med., vol. 14, pp. 283-292 (1990).
Luhmer et al., “Study of Xenon Binding in Cryptophanc-A Using Laser-Induced NMR Polarization Enhancement”, J. Am. Chem. Soc. Mar. 30, 1999, 121, 3502-3512.
MacFall et al., “Human Lung Air Spaces: Potential for MR Imaging with Hyperpolarized He-31,” Radiology, vol. 200, No. 2, pp. 553-558 (1996).
Mansfeld et al., “The use of129Xe NMR exchange spectroscopy for probing the microstructure of porous materials,” Chem. Phys. Ltrs., vol. 213, No. 1, 2, pp. 153-157 (Oct. 1, 1993).
Mansson et.al. “Characterization of diffusing capacity and perfusion of the rat lung in a lipopolysaccaride disease model using hyperp
Driehuys Bastiaan
Hall Margaret
Mansoon Sven
Marelli Claudio
Wolber Jan
Chisholm Robert F.
Jones D L
Medi--Physics, Inc.
LandOfFree
Methods for in vivo evaluation of pulmonary physiology... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for in vivo evaluation of pulmonary physiology..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for in vivo evaluation of pulmonary physiology... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2708136